Winton Group’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-96,936
| Closed | -$1.02M | – | 756 |
|
|
2024
Q3 | $1.02M | Buy |
96,936
+20,096
| +26% | +$211K | 0.07% | 316 |
|
|
2024
Q2 | $899K | Buy |
76,840
+34,136
| +80% | +$399K | 0.06% | 326 |
|
|
2024
Q1 | $900K | Buy |
+42,704
| New | +$900K | 0.06% | 328 |
|
|
2023
Q2 | – | Sell |
-10,503
| Closed | -$199K | – | 1061 |
|
|
2023
Q1 | $199K | Sell |
10,503
-29,813
| -74% | -$564K | 0.01% | 908 |
|
|
2022
Q4 | $914K | Buy |
40,316
+3,312
| +9% | +$75.1K | 0.06% | 433 |
|
|
2022
Q3 | $978K | Sell |
37,004
-8,162
| -18% | -$216K | 0.06% | 422 |
|
|
2022
Q2 | $1.12M | Buy |
45,166
+30,967
| +218% | +$765K | 0.06% | 450 |
|
|
2022
Q1 | $471K | Buy |
+14,199
| New | +$471K | 0.02% | 699 |
|
|
2021
Q4 | – | Sell |
-11,986
| Closed | -$502K | – | 1323 |
|
|
2021
Q3 | $502K | Buy |
+11,986
| New | +$502K | 0.03% | 862 |
|
|
2020
Q3 | – | Sell |
-21,240
| Closed | -$782K | – | 1589 |
|
|
2020
Q2 | $782K | Sell |
21,240
-76,240
| -78% | -$2.81M | 0.02% | 1066 |
|
|
2020
Q1 | $3.16M | Sell |
97,480
-51,330
| -34% | -$1.66M | 0.08% | 421 |
|
|
2019
Q4 | $6.1M | Buy |
+148,810
| New | +$6.1M | 0.09% | 403 |
|
|
2019
Q2 | – | Sell |
-3,841
| Closed | -$220K | – | 1259 |
|
|
2019
Q1 | $220K | Buy |
+3,841
| New | +$220K | ﹤0.01% | 929 |
|
|
2018
Q4 | – | Sell |
-2,741
| Closed | -$207K | – | 1007 |
|
|
2018
Q3 | $207K | Buy |
+2,741
| New | +$207K | ﹤0.01% | 966 |
|